These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Analgesic action and tolerance of nisidine plus with trasentine-A in general surgery. Double-blind clinical study in intramuscular administration]. Battocchio F, Negri L, Tacchetti G. Ann Ital Chir; 1981; 53(4):435-44. PubMed ID: 6188396 [No Abstract] [Full Text] [Related]
9. Effect of i.v. indoprofen on cancer pain and serum prolactin and growth hormone levels--a controlled pharmacologic study vs i. m. morphine and placebo. Pellegrini A, Massidda B, Pellegrini P, Defraia E, Usai A, Parrinello L, Bruni G, Rigamonti G, Sacchetti G. Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):483-6. PubMed ID: 6354944 [Abstract] [Full Text] [Related]
10. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. Mercadante S, Villari P, Ferrera P, Porzio G, Aielli F, Verna L, Casuccio A. J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185 [Abstract] [Full Text] [Related]
15. [Buprenorphine and nicomorphine in a double-blind trial for the control of postoperative pain (author's transl)]. Ravjower I, Alon E, Hossli G. Anasth Intensivther Notfallmed; 1981 Dec; 16(6):340-2. PubMed ID: 7325347 [Abstract] [Full Text] [Related]
17. [Controlled study of the analgesic effect and tolerability of buprenorphine in cancer patients]. Dini D, Fassio T, Gottlieb A, Gini M. Minerva Med; 1986 Jan 28; 77(3-4):93-104. PubMed ID: 3511410 [Abstract] [Full Text] [Related]
19. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain. Poulain P, Denier W, Douma J, Hoerauf K, Samija M, Sopata M, Wolfram G. J Pain Symptom Manage; 2008 Aug 28; 36(2):117-25. PubMed ID: 18411010 [Abstract] [Full Text] [Related]